Compounds > 2-(1-octynyl)adenosine
Page last updated: 2024-09-04

2-(1-octynyl)adenosine and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine

2-(1-octynyl)adenosine has been researched along with n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine in 1 studies

Compound Research Comparison

Studies
(2-(1-octynyl)adenosine)		Trials
(2-(1-octynyl)adenosine)		Recent Studies (post-2010)
(2-(1-octynyl)adenosine)		Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
2303214558

Protein Interaction Comparison

ProteinTaxonomy2-(1-octynyl)adenosine (IC50)n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50)
high affinity choline transporter 1 isoform aHomo sapiens (human)2.1002
Adenosine receptor A3Homo sapiens (human)0.0017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donegan, RK; Lieberman, RL1

Reviews

1 review(s) available for 2-(1-octynyl)adenosine and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine

ArticleYear
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.
    Journal of medicinal chemistry, 2016, Feb-11, Volume: 59, Issue:3

    Topics: Adrenergic Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Drug Discovery; Glaucoma; Humans; Ligands; Protein Kinase Inhibitors; rho-Associated Kinases; Sympathomimetics

2016